Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

C3_MGUS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — D47.2 Hospital discharge: ICD-10 — D47.2 Hospital discharge: ICD-9 — 2731 Cause of death: ICD-10 — D47.2 Cause of death: ICD-9 — 2731 Cancer registry: Topography ICD-O-3 — ANY Cancer registry: Morphology ICD-O-3 — 9765 Cancer registry: Behaviour codes — 1 4 out of 7 registries used, show all original rules.	1862
4. Check minimum number of events None	1862
5. Include endpoints None	1862
6. Filter based on genotype QC (FinnGen only)	1797

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_MGUS_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	D472
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D472
HD_ICD_9	2731
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D472
COD_ICD_9	2731
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	ANY
CANC_TOPO_EXCL
CANC_MORPH	9765
CANC_MORPH_EXCL
CANC_BEHAV	1

Similar endpoints

↥

List of similar endpoints to Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1797	802	995
Unadjusted period prevalence (%)	0.38	0.28	0.46
Median age at first event (years)	70.43	68.70	71.82

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1862: Matched controls
18620

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XW000

NOMESCO Finland

Bone marrow biopsy

50.8

307.7

756

247

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

+∞

307.7

1851

H02AB02

ATC

dexamethasone; systemic

36.0

307.7

293

C90.0

ICD-10 Finland

Multiple myeloma

+∞

307.7

326

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

34.1

307.7

378

138

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

44.3

252.7

151

AA1AA

NOMESCO Finland

Head X-ray examination

37.8

245.6

153

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

51.1

230.1

133

A04AA01

ATC

ondansetron; systemic, rectal

13.6

221.1

216

178

JN4AD

NOMESCO Finland

Body CT examination

7.7

215.4

335

514

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

2043.5

184.5

176

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

10.8

180.4

204

209

153

Kela drug reimbursment

Lenalidomid

+∞

167.3

158

C61

ICD-10 Finland

Malignant neoplasm of prostate

866.9

164.3

159

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

434.0

162.1

160

L04AX04

ATC

lenalidomide; oral

+∞

161.9

153

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

77.9

153.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.6

150.3

437

1175

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

147.9

140

JN4BD

NOMESCO Finland

Extensive body CT

6.6

147.7

259

445

WF002

NOMESCO Finland

Radical radiotherapy

59.2

132.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.2

132.0

307

684

329

Kela drug reimbursment

Lenalidomide

+∞

130.8

124

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

+∞

125.5

119

D64.9

ICD-10 Finland

Anaemia, unspecified

3.9

122.9

439

1357

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

120.1

114

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

8.9

117.8

152

184

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

116.6

870

4197

ZX112

NOMESCO Finland

Subcutaneous

23.4

114.3

L03AA02

ATC

filgrastim; parenteral

155.9

111.6

117

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

34.1

108.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

107.0

1155

6693

WW500

NOMESCO Finland

Blood transfusion

9.3

105.0

130

149

130

Kela drug reimbursment

Malignant tumour

+∞

101.0

ZX120

NOMESCO Finland

Intravenous

4.5

98.8

264

653

B03XA02

ATC

darbepoetin alfa; parenteral

9.9

97.7

115

123

R50.9

ICD-10 Finland

Fever, unspecified

3.4

94.2

409

1418

116

Kela drug reimbursment

Prostate cancer

+∞

93.5

WZC00

NOMESCO Finland

Treatment plan or consultation

2.8

92.8

675

3133

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

91.4

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.2

90.5

162

281

Z51.5

ICD-10 Finland

Palliative care

5.3

85.3

181

368

N02AA05

ATC

oxycodone; systemic

3.1

84.2

449

1749

A03FA01

ATC

metoclopramide; systemic, rectal

3.5

83.4

339

1121

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

5.1

81.1

182

388

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.1

80.6

182

390

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.5

80.5

328

1085

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

13.6

80.5

PJA12

NOMESCO Finland

Sentinel node biopsy

376.7

73.2

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

376.7

73.2

H02AB06

ATC

prednisolone; systemic

2.4

73.2

1058

6593

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.6

72.3

273

857

M04AA01

ATC

allopurinol; systemic

2.8

71.2

442

1854

HAB40

NOMESCO Finland

Wedge excision of mammary gland

22.8

67.0

XX3DW

NOMESCO Finland

Time consuming IT work

4.5

66.1

173

417

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

143.2

65.3

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

65.2

331

1239

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.3

63.9

270

907

C03CA01

ATC

furosemide; systemic

2.2

62.6

875

5263

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.2

62.4

134

274

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

7.3

61.8

131

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

61.2

513

2472

J01MA12

ATC

levofloxacin; systemic

2.6

60.3

461

2127

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.6

60.1

157

WF049

NOMESCO Finland

Radiotherapy of metastasis

312.2

59.7

A02BC02

ATC

pantoprazole; systemic

2.4

59.2

1374

10064

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

59.0

704

3945

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

58.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

58.5

680

3767

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

157.6

58.2

115

Kela drug reimbursment

Breast cancer

+∞

57.6

B01AB05

ATC

enoxaparin; parenteral

2.3

57.4

674

3744

J05AB01

ATC

aciclovir; systemic

2.4

57.1

492

2392

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

56.5

170

454

B01AB10

ATC

tinzaparin; parenteral

3.4

56.4

218

690

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.1

56.4

167

441

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

564.5

55.9

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

9.0

55.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

54.2

461

2222

L02AE02

ATC

leuprorelin; implant, parenteral

77.6

53.3

ZX108

NOMESCO Finland

Inhalation

17.3

53.2

B03XA01

ATC

erythropoietin; parenteral

12.7

53.1

JN4CD

NOMESCO Finland

Very extensive body CT

7.9

52.5

L01AA03

ATC

melphalan; systemic

+∞

52.3

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

267.8

51.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.3

51.0

215

717

WW300

NOMESCO Finland

Transfer of autologic stem cells

511.4

50.7

A11CC03

ATC

alfacalcidol; systemic

5.6

50.5

186

Z3231

NOMESCO Finland

Registered nurse

2.2

48.7

578

3184

TK800

NOMESCO Finland

Hemodialysis

6.1

48.3

144

L03AA13

ATC

pegfilgrastim; parenteral

164.1

46.0

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

46.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

46.0

294

1230

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.0

45.6

226

827

A04AA02

ATC

granisetron; systemic, transdermal

85.7

45.1

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

45.0

UJF32

NOMESCO Finland

Coloscopy

2.1

44.8

572

3223

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.3

44.6

181

L57.0

ICD-10 Finland

Actinic keratosis

2.8

43.7

242

939

HA1AA

NOMESCO Finland

X-ray mammography

5.1

43.5

189

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.2

43.3

186

N03AX16

ATC

[U] pregabalin

2.1

43.1

511

2793

L02BB03

ATC

bicalutamide; oral

+∞

42.9

D75.2

ICD-10 Finland

Essential thrombocytosis

10.9

42.7

M05BX04

ATC

denosumab; parenteral

3.4

42.7

161

500

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

42.3

280

1189

N02AX02

ATC

tramadol; systemic, rectal

1.9

42.1

872

5806

GD1AD

NOMESCO Finland

Thorax CT examination

3.5

41.9

151

455

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

41.8

ZXE00

NOMESCO Finland

One hour or less

2.0

41.5

739

4668

N18.8

ICD-10 Finland

Other chronic renal failure

4.4

41.5

107

254

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

39.9

259

1087

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

39.8

483

2653

Z2221

NOMESCO Finland

Medical doctor

2.1

39.6

532

3034

R4110

NOMESCO Finland

Physiotherapy

2.0

39.2

553

3207

WX402

NOMESCO Finland

General anaesthesia

2.3

38.8

338

1623

J01DB01

ATC

cefalexin; oral

2.2

38.7

1509

12297

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

38.1

199

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

104.8

37.9

WF003

NOMESCO Finland

Adjuvant radiotherapy

374.6

37.1

D70.89

ICD-10 Finland

Neutropenic splenomegaly

10.5

37.0

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.2

36.6

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

36.2

485

2749

N02BE01

ATC

paracetamol; systemic, rectal

2.6

36.0

1667

14287

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

36.0

687

4391

ZZR00

NOMESCO Finland

Flap of skin

11.5

34.5

WZC30

NOMESCO Finland

Teaching

2.4

34.5

267

1213

JN6AD

NOMESCO Finland

CT of torso and neck

10.8

34.1

WF004

NOMESCO Finland

Palliative radiotherapy

343.3

34.0

Y77

ICPC

Malignant neoplasm prostate

178.2

33.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

33.7

165

597

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.5

33.6

235

1019

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.4

33.5

128

J01MA14

ATC

moxifloxacin; systemic

2.6

33.5

213

882

393

Kela drug reimbursment

Pomalidomide

+∞

33.4

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

12.4

33.3

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

32.1

446

2546

J05AB11

ATC

valaciclovir; oral

2.3

31.9

289

1402

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.2

31.9

136

454

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.6

31.9

108

312

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

5.3

31.8

127

Kela drug reimbursment

Transplant complication

8.2

31.7

L04AX06

ATC

pomalidomide; oral

+∞

31.3

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

31.3

Z3226

NOMESCO Finland

Physiotherapist

2.1

31.2

374

2023

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

31.1

377

2048

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.8

31.1

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.0

30.8

144

507

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.5

30.8

109

324

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

30.7

467

2744

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

30.4

108

322

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.2

30.2

122

394

E0000UV, ,

ATC

1.8

30.2

748

5109

L02BG04

ATC

letrozole; oral

59.4

30.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

30.0

176

700

L28

ICPC

Limited function/disability (L)

1.9

29.9

452

2649

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.7

29.8

G62.8

ICD-10 Finland

Other specified polyneuropathies

7.4

29.7

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

157.5

29.7

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

8.6

29.7

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

29.2

1507

Kela drug reimbursment

Pomalidomide

+∞

29.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.1

29.2

212

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

29.1

225

1018

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

81.5

28.8

A12AA04

ATC

calcium carbonate; oral

5.5

28.6

105

N19

ICD-10 Finland

Unspecified kidney failure

3.1

28.6

121

402

L04AA06

ATC

mycophenolic acid; systemic

5.8

28.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

28.2

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

28.2

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

+∞

28.2

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

28.2

S18

ICPC

Laceration/cut

1.7

28.1

868

6270

WW200

NOMESCO Finland

Immunization

4.4

28.0

166

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

28.0

660

4421

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

65.0

28.0

AA1AD

NOMESCO Finland

CT of head and brain

1.8

28.0

636

4216

E85.9

ICD-10 Finland

Amyloidosis, unspecified

33.3

27.8

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

27.7

219

1000

HAC20

NOMESCO Finland

Total mastectomy

147.2

27.7

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

27.4

414

2418

A28

ICPC

Limited function/disability NOS

1.9

27.2

444

2658

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

27.1

M05BA04

ATC

alendronic acid; oral

2.3

27.0

237

1131

ZXD05

NOMESCO Finland

Urgent procedure

1.8

27.0

578

3757

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

26.8

104

328

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

26.5

1172

9267

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.9

26.4

214

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

26.2

193

854

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

25.8

256

1283

M13.9

ICD-10 Finland

Arthritis, unspecified

2.5

25.8

166

690

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

25.6

338

1881

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.1

25.6

178

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

25.5

218

1028

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

25.4

317

1729

L01XX05

ATC

hydroxycarbamide; oral

4.9

25.4

117

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

25.3

470

2921

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

25.3

709

4951

E83.50

ICD-10 Finland

Hypercalcemia

6.2

25.1

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

25.1

398

Kela drug reimbursment

Ixazomib

+∞

25.1

P01BA02

ATC

hydroxychloroquine; oral

2.4

24.7

184

818

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.3

24.6

153

H02AB04

ATC

methylprednisolone; systemic

2.0

24.5

306

1668

H02AB07

ATC

prednisone; oral

2.0

24.4

293

1575

R53

ICD-10 Finland

Malaise and fatigue

1.8

24.4

466

2915

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

24.4

248

1254

ZX090

NOMESCO Finland

Other technic of radiotherapy

49.0

24.3

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

24.1

687

4803

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

24.0

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

24.0

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

24.0

1505

Kela drug reimbursment

Ixazomib

+∞

24.0

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.5

23.9

C50.99

ICD-10 Finland

Breast, unspecified

243.0

23.7

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

243.0

23.7

R06.0

ICD-10 Finland

Dyspnoea

1.7

23.7

571

3812

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.7

23.7

UKC02

NOMESCO Finland

Cystoscopy

1.9

23.4

345

1987

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.1

23.3

C08CA01

ATC

amlodipine; oral

1.6

23.3

867

6473

WVA20

NOMESCO Finland

Medicine administration

4.1

23.1

156

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

23.1

226

1125

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.6

23.0

145

596

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

23.0

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

23.0

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

23.0

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.6

22.9

212

J01CA04

ATC

amoxicillin; systemic

1.7

22.7

1397

11804

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

232.7

22.7

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

121.5

22.6

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5.0

22.3

XKD00

NOMESCO Finland

Uroflowmetry

1.9

22.2

336

1949

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

8.0

22.2

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

22.1

847

6342

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

21.9

L04AD01

ATC

ciclosporin; systemic

5.1

21.9

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

222.5

21.6

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

116.4

21.6

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

116.4

21.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

21.5

127

506

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

21.5

257

1377

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

21.4

304

1726

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

21.3

117

449

E85.89

ICD-10 Finland

Other amyloidosis

50.6

21.1

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

50.6

21.1

D64.8

ICD-10 Finland

Other specified anaemias

4.0

20.9

150

C03DA01

ATC

spironolactone; oral

1.9

20.8

301

1719

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

20.7

106

392

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

212.3

20.6

ZXA05

NOMESCO Finland

Left side

1.7

20.6

492

3257

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

20.5

414

2615

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

6.6

20.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.0

20.4

317

L04AX03

ATC

methotrexate; systemic

2.1

20.3

199

989

WZC15, ,

NOMESCO Finland

48.6

20.2

C07AB07

ATC

bisoprolol; oral

1.6

20.1

1068

8560

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

20.1

114

445

B82

ICPC

Anaemia other/unspecified

3.2

20.0

257

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.9

19.9

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.8

19.9

103

383

J01FF01

ATC

clindamycin; systemic

1.7

19.9

489

3256

A04AA55

ATC

palonosetron, combinations; systemic

+∞

19.8

1XX32, ,

NOMESCO Finland

+∞

19.8

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

19.8

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

19.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

19.8

519

3513

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.0

19.7

296

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

19.6

139

603

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

19.6

282

1605

L02BA01

ATC

tamoxifen; oral

106.2

19.6

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

202.1

19.6

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

202.1

19.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.1

19.5

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

19.5

331

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

19.4

174

835

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

19.3

154

703

M79.6

ICD-10 Finland

Pain in limb

1.6

19.3

744

5522

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

19.3

165

776

R80

ICD-10 Finland

Isolated proteinuria

6.4

19.3

A02BC01

ATC

omeprazole; systemic

1.6

19.3

538

3696

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

31.6

19.3

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.8

19.2

306

1799

J01MA02

ATC

ciprofloxacin; systemic

1.6

19.1

725

5359

H02AB09

ATC

hydrocortisone; systemic

4.0

18.8

139

WW409

NOMESCO Finland

Other aferesis

+∞

18.8

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

18.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

18.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

18.7

288

1674

M54.5

ICD-10 Finland

Low back pain

1.6

18.6

609

4344

L04AX02

ATC

thalidomide; oral

191.9

18.6

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.0

18.6

136

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

18.5

715

5295

3AC01, ,

NOMESCO Finland

5.8

18.5

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

18.5

138

613

N06AX21

ATC

duloxetine; oral

2.0

18.3

207

1085

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

44.5

18.2

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

44.5

18.2

R4190

NOMESCO Finland

Nutritional therapy

4.0

18.2

129

N03AX12

ATC

[U] gabapentin; oral

1.8

18.1

325

1979

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

18.0

780

5917

S97

ICPC

Chronic ulcer skin

2.2

18.0

160

764

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.6

18.0

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

16.7

17.9

WX002

NOMESCO Finland

Sedation and analgesia

1.7

17.9

375

2385

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

17.8

147

682

XW000, ,

SPAT

67.3

17.7

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

17.7

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

17.7

9671/3-C42.1

ICD-O-3

Lymphoplasmacytic lymphoma of bone marrow

+∞

17.7

C90

ICD-10 Finland

Multiple myeloma and malignant plasma cell neoplasms

+∞

17.7

A46

ICD-10 Finland

Erysipelas

1.8

17.7

316

1918

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

96.0

17.6

A06AD11

ATC

lactulose; oral

1.8

17.4

328

2021

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.8

17.4

138

L04AA01

ATC

[U] ciclosporin

5.0

17.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.3

17.3

211

L04AX01

ATC

azathioprine; systemic

2.8

17.1

315

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

17.0

289

1727

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

50.5

17.0

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

7.6

17.0

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

7.2

17.0

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.0

16.9

251

NK6AN

NOMESCO Finland

Total body bone isotope imaging

22.1

16.9

I50.0

ICD-10 Finland

Congestive heart failure

1.9

16.8

216

1182

TAB00

NOMESCO Finland

Lumbar puncture

2.8

16.8

324

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

16.7

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

16.7

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

16.7

L01BC06

ATC

capecitabine; oral

+∞

16.7

137

Kela drug reimbursment

Uraemia requiring dialysis

6.5

16.7

M05BA02

ATC

clodronic acid; systemic

171.5

16.5

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

14.4

16.3

R02

ICPC

Shortness of breath/dyspnoea

1.8

16.3

272

1616

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

4.1

16.2

113

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

16.2

336

2125

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

4.4

16.2

A08

ICPC

Swelling

2.4

16.2

116

506

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.7

16.2

319

Z94.0

ICD-10 Finland

Kidney transplant status

6.8

16.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

16.0

348

2229

212

Kela drug reimbursment

Gout

3.2

16.0

201

V03AE01

ATC

polystyrene sulfonate; oral

4.5

15.9

R60.0

ICD-10 Finland

Localized oedema

1.8

15.9

258

1521

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

15.8

250

R5110, ,

SPAT

2.1

15.8

149

729

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

15.7

335

2134

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

15.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

15.6

WW402

NOMESCO Finland

Leucoferesis

+∞

15.6

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

15.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

15.6

ZX070

NOMESCO Finland

Intensity modified radiotherapy

85.8

15.6

R51.80

ICD-10 Finland

Headache

1.8

15.6

241

1399

SPAT1255

SPAT

Intravenous administration of medicine

2.1

15.6

147

719

J01FA06

ATC

roxithromycin; oral

1.5

15.5

688

5200

ZXC50

NOMESCO Finland

Cryotherapy

3.3

15.5

184

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

161.3

15.5

GA5AA

NOMESCO Finland

Rib X-ray examination

14.9

15.4

WX892

NOMESCO Finland

Monitored bed care

2.1

15.3

157

792

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

15.2

772

5993

ZXC20

NOMESCO Finland

Use of chemical agents

4.1

15.2

101

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.5

15.2

147

R03AC02

ATC

salbutamol; inhalant

1.5

15.2

907

7275

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

15.1

325

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

15.0

112

497

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

6.6

14.9

N05CF01

ATC

zopiclone; oral

1.5

14.8

594

4385

XQ848

NOMESCO Finland

Dermatological photography

3.3

14.8

179

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

32.0

14.8

R06AE07

ATC

cetirizine; oral

1.5

14.8

659

4975

D07AC01

ATC

betamethasone; topical

1.5

14.8

639

4794

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

14.7

248

1476

TGC00

NOMESCO Finland

Bronchial lavation

3.1

14.6

196

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

5.7

14.6

SPAT1229

SPAT

Assessment of need for aid

1.9

14.6

181

977

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

14.6

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

14.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

14.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

14.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

14.6

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

14.5

167

878

A06AH03

ATC

naloxegol; oral

10.9

14.5

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

36.3

14.4

ZX100

NOMESCO Finland

Oral

4.4

14.3

SPAT1263

SPAT

Sampling

1.5

14.3

738

5730

J01FA10

ATC

azithromycin; systemic

1.5

14.3

830

6594

C08CA05

ATC

nifedipine; systemic

2.1

14.2

147

745

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

14.1

101

440

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

42.8

14.1

DHB00

NOMESCO Finland

Excision of lesion of external nose

14.5

14.1

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.6

14.0

337

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.7

14.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

14.0

332

2168

N02BF02

ATC

pregabalin; oral

2.3

14.0

110

500

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

14.0

557

4099

ZXA10

NOMESCO Finland

Bilateral

1.6

13.9

363

2427

B01AB04

ATC

dalteparin; parenteral

2.4

13.9

387

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

12.8

13.9

N02BF01

ATC

gabapentin; oral

2.0

13.9

157

821

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

13.9

349

2313

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

24.0

13.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

13.8

451

3178

306

Kela drug reimbursment

Erythropoietin and darbepoetin

20.2

13.8

R31

ICD-10 Finland

Unspecified haematuria

1.8

13.8

206

1182

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.2

13.7

117

550

N17.8

ICD-10 Finland

Other acute renal failure

4.4

13.6

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.9

13.6

174

950

C421, 9761, 1

ICD-O-3

+∞

13.6

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

13.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

13.6

L01XX50

ATC

[U] ixazomib

+∞

13.6

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

13.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

13.6

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

13.5

150

779

SPAT1254

SPAT

Administration of medicine

1.7

13.4

291

1856

A04

ICPC

Weakness/tiredness general

1.7

13.4

267

1666

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

13.3

282

1787

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.8

13.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

13.2

240

1459

N18.0

ICD-10 Finland

End-stage renal disease

4.4

13.1

A07AA09

ATC

vancomycin; oral

3.9

13.1

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.8

13.1

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.8

13.0

104

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

13.0

425

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

12.9

267

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

12.9

543

4026

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

6.2

12.9

ZY010

NOMESCO Finland

Hospital outpatient

2.7

12.9

250

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

12.9

394

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

13.1

12.9

ZXC15

NOMESCO Finland

Use of photodynamic technique

5.1

12.9

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

12.8

119

NB4AA

NOMESCO Finland

Scapula X-ray examination

11.6

12.8

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.5

12.8

129

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

12.7

252

A02BC05

ATC

esomeprazole; systemic

1.4

12.7

698

5450

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

12.7

784

6258

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

4.4

12.6

A07AA02

ATC

nystatin; oral

2.1

12.6

115

555

B74

ICPC

Malignant neoplasm blood other

32.3

12.6

WX320

NOMESCO Finland

Spinalanesthesy

1.5

12.6

452

3243

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

12.5

197

1147

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

12.5

L02AE04

ATC

triptorelin; parenteral

+∞

12.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

12.5

L01XG03

ATC

ixazomib; oral

+∞

12.5

2731A

ICD-9 Finland

Disorders of plasma protein metabolism, Monoclonal paraproteinaemia

+∞

12.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

12.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

12.5

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

12.5

407

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

12.4

286

1849

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

130.9

12.4

WX1BG

NOMESCO Finland

Total body MRI with high intensity magnet

130.9

12.4

Z49.2

ICD-10 Finland

Other dialysis

5.7

12.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

12.4

169

941

SPAT1262

SPAT

Handing over of treatment supplies

1.6

12.4

352

2396

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.8

12.3

234

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.2

12.3

158

KAC10

NOMESCO Finland

Total nephrectomy with capsule

37.8

12.2

A79

ICPC

Malignancy NOS

37.8

12.2

D07AB08

ATC

desonide; topical

1.8

12.2

185

1065

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

12.2

114

556

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

12.2

134

694

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

12.1

106

503

A03

ICPC

Fever

1.8

12.1

210

1258

M79.1

ICD-10 Finland

Myalgia

1.7

12.1

225

1376

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

12.0

100

465

S29

ICPC

Skin symptom/complaint other

1.6

12.0

323

2168

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

12.0

314

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.7

11.9

R11

ICD-10 Finland

Nausea and vomiting

1.9

11.9

144

771

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

47.0

11.9

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

11.8

328

J94.8

ICD-10 Finland

Other specified pleural conditions

3.7

11.8

102

SPAT1211

SPAT

Application of soft bandage

1.9

11.8

160

890

G04BE03

ATC

sildenafil; oral

9.0

11.7

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

11.7

173

G04CA02

ATC

tamsulosin; oral

1.5

11.7

522

3903

N06AX11

ATC

mirtazapine; oral

1.5

11.7

562

4263

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.1

11.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.6

11.6

108

R4120

NOMESCO Finland

Occupational therapy

2.0

11.5

119

602

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

11.5

1249

10933

XF402

NOMESCO Finland

ECG with work load test

1.7

11.5

227

1408

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

11.5

316

2130

K92.1

ICD-10 Finland

Melaena

2.1

11.5

116

582

NF3AA

NOMESCO Finland

Femur X-ray examination

3.0

11.5

175

R04.0

ICD-10 Finland

Epistaxis

1.8

11.5

163

919

L03

ICPC

Low back symptom/complaint

1.5

11.5

449

3269

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

11.5

L02BG03

ATC

anastrozole; oral

+∞

11.5

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

11.5

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

11.5

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

11.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

11.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

11.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

11.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

11.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

11.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

11.5

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

120.7

11.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

120.7

11.4

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.6

11.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

11.4

238

1499

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

11.4

541

4091

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

11.4

308

2069

M25.5

ICD-10 Finland

Pain in joint

1.5

11.4

497

3699

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.9

11.3

188

SPAT1260

SPAT

Consultation of another employee

1.6

11.3

319

2166

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.5

11.2

J01AA02

ATC

doxycycline; systemic

1.5

11.2

1350

12013

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.6

11.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

11.2

605

4686

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

11.1

235

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

11.1

110

549

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

11.1

448

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

11.0

185

5BA08, ,

NOMESCO Finland

9.3

11.0

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.3

11.0

127

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

11.0

430

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

10.9

160

911

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

43.6

10.9

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.5

10.9

108

ZQZ00

NOMESCO Finland

Treatment of several skin areas

15.6

10.8

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

10.8

151

847

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

10.8

468

3471

D06BB10

ATC

imiquimod; topical

2.3

10.8

361

SPAT1153

SPAT

Removal of sutures

1.4

10.8

541

4126

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

8.9

10.8

SPAT1088

SPAT

Blood transfusion

9.6

10.7

G61.8

ICD-10 Finland

Other inflammatory polyneuropathies

17.9

10.7

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.8

10.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.4

10.7

109

Z2446

NOMESCO Finland

Social worker

2.1

10.7

481

B80

ICPC

Iron deficiency anaemia

2.9

10.7

166

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

10.7

140

770

U14

ICPC

Kidney symptom/complaint

3.4

10.6

115

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.0

10.5

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

10.1

10.5

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

10.5

315

L17

ICPC

Foot/toe symptom/complaint

1.4

10.5

503

3801

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

10.5

309

R42

ICD-10 Finland

Dizziness and giddiness

1.5

10.5

436

3207

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

10.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

10.4

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

10.4

A04AD12

ATC

aprepitant; systemic

+∞

10.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

10.4

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

10.4

390

Kela drug reimbursment

Ibrutinib

+∞

10.4

1512

Kela drug reimbursment

Ibrutinib

+∞

10.4

9731/3-C42.1

ICD-O-3

Plasmacytoma, NOS, of bone marrow

+∞

10.4

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

10.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

10.4

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

10.4

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

10.4

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

10.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

10.4

730

5896

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.9

10.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

10.4

309

2119

XF404

NOMESCO Finland

Ambulatory ECG

1.7

10.3

187

1133

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

10.3

107

543

PJA10

NOMESCO Finland

Exploration of lymph nodes

8.8

10.3

B02.9

ICD-10 Finland

Zoster without complication

1.9

10.3

130

707

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

10.2

233

L03AB05

ATC

interferon alfa-2b; parenteral

23.5

10.2

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

10.2

109

559

A98

ICPC

Health maint/preventive medicine

1.7

10.2

1684

15787

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

10.2

193

1185

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

10.1

162

947

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

10.1

209

1312

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

10.1

365

207

Kela drug reimbursment

Chronic arrhythmias

1.5

10.1

372

2668

ZZA00

NOMESCO Finland

Split skin graft

2.8

10.1

183

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

10.0

118

626

EBA10

NOMESCO Finland

Operative extraction of tooth

1.8

10.0

139

779

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.0

10.0

110

571

WX722

NOMESCO Finland

PEEP

2.1

9.9

455

SPAT1336

SPAT

Request for examination

2.3

9.9

330

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

12.2

9.8

B01AF02

ATC

apixaban; oral

1.6

9.8

287

1958

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.5

9.8

262

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

9.8

531

4092

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

8.2

9.8

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

9.8

325

R4180

NOMESCO Finland

Podiatric therapy

3.6

9.8

ZXA00

NOMESCO Finland

Right side

1.4

9.8

473

3573

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

9.8

473

3573

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

9.8

TQW80

NOMESCO Finland

Local dermatologic skincare

2.6

9.8

209

L04AA13

ATC

[U] leflunomide

2.7

9.7

192

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.7

9.7

192

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

9.7

145

830

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

13.4

9.7

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

9.7

252

J20

ICD-10 Finland

Acute bronchitis

1.7

9.7

164

976

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

55.3

9.7

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

55.3

9.7

3XA02, ,

NOMESCO Finland

55.3

9.7

R55

ICD-10 Finland

Syncope and collapse

1.6

9.6

231

1505

H05BX01

ATC

cinacalcet; oral

5.3

9.6

1XC02, ,

NOMESCO Finland

7.9

9.6

N30.0

ICD-10 Finland

Acute cystitis

1.6

9.6

258

1727

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.8

9.6

D07AC13

ATC

mometasone; topical

1.4

9.6

475

3604

J01FA09

ATC

clarithromycin; systemic

1.4

9.5

459

3462

J12.8

ICD-10 Finland

Other viral pneumonia

4.6

9.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.1

9.5

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.1

9.5

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.0

9.5

139

B01AA03

ATC

warfarin; systemic

1.4

9.5

453

3412

Z01.2

ICD-10 Finland

Dental examination

1.4

9.5

642

5136

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.3

9.5

103

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

100.5

9.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

100.5

9.4

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.9

9.4

145

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

9.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

9.4

128

Kela drug reimbursment

Cancers of female genital organs

+∞

9.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

9.4

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

9.4

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

9.4

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

9.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

9.4

Z52.89

ICD-10 Finland

Donor of other organ or tissue

+∞

9.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

9.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

9.4

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

9.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

9.4

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

9.3

250

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.7

9.3

185

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

9.3

543

4233

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

9.3

823

6865

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.0

9.2

136

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

9.2

313

2206

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

9.2

475

R01AD09

ATC

mometasone; nasal

1.4

9.2

647

5203

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

9.2

110

588

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.9

9.1

153

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

15.7

9.0

V03AE03

ATC

lanthanum carbonate; oral

10.1

9.0

D47.7

ICD-10 Finland

Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

36.9

9.0

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

9.0

224

R05

ICPC

Cough

1.4

9.0

389

2874

L88

ICPC

Rheumatoid/seropositive arthritis

2.2

9.0

364

WF099

NOMESCO Finland

Other radiotherapy

18.7

8.9

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

8.9

135

777

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

8.9

319

XG405

NOMESCO Finland

Education on PEF monitoring

3.4

8.9

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

24.1

8.9

R01AD08

ATC

fluticasone; nasal

1.4

8.9

409

3054

SPAT1125

SPAT

Stoma care and guidance

3.3

8.9

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.9

8.9

104

552

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

8.6

8.8

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.0

8.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

8.7

126

715

R74

ICPC

Upper respiratory infection acute

1.5

8.7

352

2566

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.1

8.7

114

GDC00

NOMESCO Finland

Lobectomy of lung

50.2

8.7

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

8.7

383

2839

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

8.6

466

WX882

NOMESCO Finland

High dependency care

2.5

8.6

205

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

8.6

108

587

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

8.6

409

3074

L02AE03

ATC

goserelin; implant

16.4

8.6

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

16.4

8.6

C09CA06

ATC

candesartan; oral

1.4

8.5

401

3004

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.1

8.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

8.5

528

4148

B02AA02

ATC

tranexamic acid; systemic

1.7

8.5

171

1066

WW400

NOMESCO Finland

Plasmaferesis

27.6

8.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

8.5

148

888

-54

ICPC

Repair/fix-suture/cast/prosth device

2.8

8.5

154

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.4

8.5

237

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.9

8.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

90.5

8.4

Z51.0

ICD-10 Finland

Radiotherapy session

90.5

8.4

N06AA09

ATC

amitriptyline; systemic

1.6

8.4

178

1124

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.6

8.4

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

8.4

953

8200

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.2

8.4

106

E000001, ,

ATC

1.5

8.3

303

2161

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

8.3

160

985

K62.7

ICD-10 Finland

Radiation proctitis

+∞

8.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

8.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

8.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

8.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

8.3

M49.5*C90.0

ICD-10 Finland

Vertebral fracture due to multiple myeloma

+∞

8.3

L01EL01

ATC

ibrutinib; oral

+∞

8.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

8.3

WX1CG

NOMESCO Finland

Extensive total body MRI with high intensity magnet

+∞

8.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

8.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

8.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

8.3

XF602

NOMESCO Finland

Bloodpressure monitoring

3.6

8.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.6

8.3

A10AB05

ATC

insulin aspart; parenteral

1.7

8.3

141

840

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

8.3

290

C10AC01

ATC

colestyramine; oral

2.6

8.3

179

NG1DA

NOMESCO Finland

X-ray of knees

2.8

8.2

145

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

3.4

8.2

R06AX27

ATC

desloratadine; oral

1.4

8.2

353

2601

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

14.5

8.2

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

7.6

8.2

B99

ICPC

Blood/lymph/spleen disease other

7.6

8.2

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.4

8.2

R03DC03

ATC

montelukast; oral

1.5

8.1

244

1672

K08.3

ICD-10 Finland

Retained dental root

1.7

8.1

137

814

S21

ICPC

Skin texture symptom/complaint

1.5

8.1

227

1532

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.0

8.1

119

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.2

8.1

M01AH05

ATC

etoricoxib; oral

1.3

8.1

946

8160

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

8.0

224

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.0

8.0

ED1AA

NOMESCO Finland

Mandibular X-ray examination

9.0

8.0

A02BC03

ATC

lansoprazole; oral

1.4

8.0

511

4025

Z31.5

ICD-10 Finland

Genetic counselling

2.6

8.0

176

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.8

8.0

136

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.1

8.0

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

22.1

8.0

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.8

8.0

142

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

8.0

133

788

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

8.0

148

TKC22

NOMESCO Finland

Catheterisation instruction

2.6

7.9

177

A07EA06

ATC

budesonide; oral, local oral

2.3

7.9

257

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

7.9

369

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

6.6

7.9

L01XX35

ATC

anagrelide; oral

13.1

7.9

SPAT1301

SPAT

No procedures

1.4

7.9

557

4460

J01DA01

ATC

[U] cefalexin

1.3

7.8

1013

8842

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.7

7.8

155

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

7.8

364

U71

ICPC

Cystitis/urinary infection other

1.9

7.8

100

547

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

3.3

7.8

ZX114

NOMESCO Finland

Intramuscular

3.8

7.8

D11

ICPC

Diarrhoea

1.7

7.8

150

925

J01FA15

ATC

telithromycin; oral

1.7

7.7

143

872

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

7.7

232

1590

R52.9

ICD-10 Finland

Pain, unspecified

1.6

7.7

161

1013

J01DA06

ATC

[U] cefuroxime

1.5

7.7

218

1474

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

7.7

129

765

X76

ICPC

Malignant neoplasm breast female

45.2

7.7

C09AA05

ATC

ramipril; oral

1.4

7.7

533

4249

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.2

7.7

286

SPAT1216

SPAT

Assessment of functional ability

1.4

7.7

319

2332

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

7.7

290

2082

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

7.7

229

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.2

7.7

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

7.6

204

1362

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

7.6

287

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

7.6

101

558

A99

ICPC

Disease/condition unspecnature/site

1.6

7.6

162

1024

L01BA01

ATC

methotrexate; systemic

2.1

7.6

327

K03.66

ICD-10 Finland

Tooth plaque

1.8

7.6

115

662

6BA02, ,

NOMESCO Finland

18.4

7.6

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

7.6

146

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

7.6

128

761

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

25.1

7.6

R2110

NOMESCO Finland

Giving the first information

1.9

7.6

502

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

7.5

642

5277

RD210, ,

NOMESCO Finland

3.3

7.5

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.1

7.5

C02AC05

ATC

moxonidine; oral

1.9

7.5

532

M48.0

ICD-10 Finland

Spinal stenosis

1.5

7.5

256

1802

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

7.5

360

2703

M03BX02

ATC

tizanidine; oral

1.3

7.5

923

7986

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

7.5

343

2554

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

7.5

290

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

7.4

149

928

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.6

7.4

186

1224

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

80.4

7.4

C50

ICD-10 Finland

Malignant neoplasm of breast

80.4

7.4

D89.2

ICD-10 Finland

Hypergammaglobulinaemia, unspecified

80.4

7.4

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

7.4

239

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.5

7.4

RS221, ,

NOMESCO Finland

3.4

7.4

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

13.4

7.4

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

7.4

514

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

7.3

171

1106

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

7.3

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

7.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

7.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

7.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

7.3

L01FC01

ATC

daratumumab; parenteral

+∞

7.3

L01CB01

ATC

etoposide; systemic

+∞

7.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

7.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

7.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

7.3

NB4DA

NOMESCO Finland

Bilateral scapula X-ray examination

+∞

7.3

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

7.3

102

574

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

6.9

7.3

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.9

7.3

523

M10.9

ICD-10 Finland

Gout, unspecified

1.6

7.2

150

943

L04AD02

ATC

tacrolimus; systemic

5.8

7.2

C08CA02

ATC

felodipine; oral

1.5

7.2

205

1388

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.8

7.2

111

643

N32.0

ICD-10 Finland

Bladder-neck obstruction

3.7

7.2

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.3

7.2

217

R19.5

ICD-10 Finland

Other faecal abnormalities

2.9

7.2

111

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

30.1

7.1

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

20.1

7.1

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

20.1

7.1

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

20.1

7.1

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

7.1

221

1525

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

7.1

122

729

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

7.1

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.9

7.1

TEA00

NOMESCO Finland

Biopsy of lip

3.8

7.1

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.0

7.1

399

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

5.6

7.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.0

391

3005

WPA13

NOMESCO Finland

Palliative consultation

10.1

7.0

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

10.1

7.0

SPAT1127

SPAT

Enema

3.6

7.0

N18

ICD-10 Finland

Chronic kidney disease

3.1

7.0

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.2

7.0

WX212

NOMESCO Finland

Femoral plexus blockade

2.4

7.0

207

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

7.0

530

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

7.0

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

7.0

332

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.8

7.0

553

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.8

6.9

119

M02AA07

ATC

piroxicam; topical

1.3

6.9

632

5233

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

6.9

125

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.5

6.9

160

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.8

6.9

114

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.3

6.8

203

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

6.8

121

730

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

8.3

6.8

JFF23

NOMESCO Finland

Transversostomy

8.3

6.8

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.8

6.8

M01AH01

ATC

celecoxib; oral

1.4

6.8

303

2242

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

11.0

6.8

L95

ICPC

Osteoporosis

2.0

6.8

363

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

6.8

173

R33

ICD-10 Finland

Retention of urine

1.6

6.8

162

1055

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.1

6.8

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

6.8

595

4897

N03.5

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis

40.2

6.8

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

40.2

6.8

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.7

6.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.3

6.8

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.9

6.8

104

S77

ICPC

Malignant neoplasm of skin

16.7

6.7

G47.3

ICD-10 Finland

Sleep apnoea

1.4

6.7

363

2775

E87.5

ICD-10 Finland

Hyperkalaemia

2.4

6.7

180

XQ800

NOMESCO Finland

Prick test

1.9

6.7

464

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.9

6.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

6.7

289

2125

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.2

6.7

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

7.2

6.7

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.4

6.7

N63

ICD-10 Finland

Unspecified lump in breast

2.1

6.7

283

N06AX16

ATC

venlafaxine; oral

1.6

6.7

164

1074

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

6.7

472

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

6.7

218

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

22.6

6.7

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

6.7

257

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

6.6

119

720

SPAT1325

SPAT

Vaccination

1.3

6.6

619

5132

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.3

6.6

225

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

6.6

157

1020

A10BH05

ATC

linagliptin; oral

1.7

6.6

113

675

B07.9

ICD-10 Finland

Verruca simplex

2.3

6.6

200

H26.3

ICD-10 Finland

Drug-induced cataract

5.9

6.6

DAB00

NOMESCO Finland

Excision of lesion of auricle

5.5

6.6

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

12.3

6.6

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.2

6.6

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.2

6.6

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.6

417

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.5

6.6

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

6.6

482

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

6.6

123

754

A97

ICPC

No disease

1.4

6.5

286

2108

K29.6

ICD-10 Finland

Other gastritis

3.0

6.5

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.9

6.5

XX2RW, ,

NOMESCO Finland

6.2

6.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.2

6.5

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.5

6.5

153

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

6.4

127

789

D07AD01

ATC

clobetasol; topical

1.4

6.4

259

1881

D89.1

ICD-10 Finland

Cryoglobulinaemia

70.1

6.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

70.1

6.4

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

70.1

6.4

DAB10

NOMESCO Finland

Partial excision of auricle

70.1

6.4

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

70.1

6.4

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.3

6.4

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

6.4

288

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

7.4

6.4

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

6.4

255

P01AB01

ATC

metronidazole; oral, rectal

1.3

6.4

587

4852

XG466

NOMESCO Finland

Sleep oxymetry

2.1

6.4

269

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

6.4

569

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.4

6.3

185

R03BB04

ATC

tiotropium bromide; inhalant

1.5

6.3

201

1393

Z71.8

ICD-10 Finland

Other specified counselling

1.3

6.3

427

3377

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

6.6

6.3

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.3

329

2498

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

5.2

6.3

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.6

6.3

131

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

6.3

345

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.9

6.3

438

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

18.1

6.3

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

18.1

6.3

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

18.1

6.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

6.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

6.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

6.3

C91.7

ICD-10 Finland

Other lymphoid leukaemia

+∞

6.3

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

+∞

6.3

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

6.3

C90.1

ICD-10 Finland

Plasma cell leukaemia

+∞

6.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

6.3

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

6.3

N16.1*C90.0

ICD-10 Finland

Renal tubulo-interstitial disorders in multiple myeloma

+∞

6.3

L02BX02

ATC

degarelix; parenteral

+∞

6.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

6.3

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

+∞

6.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

6.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

6.3

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

+∞

6.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

6.3

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

6.2

102

602

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

26.8

6.2

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.2

824

7135

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.2

6.2

245

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.8

6.2

521

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

6.2

433

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

5.0

6.2

B05DA

ATC

Isotonic solutions

5.0

6.2

M81.5

ICD-10 Finland

Idiopathic osteoporosis

3.5

6.2

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.5

6.2

M54.1

ICD-10 Finland

Radiculopathy

2.0

6.2

341

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.4

6.2

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.2

6.2

K86.2

ICD-10 Finland

Cyst of pancreas

3.3

6.1

R07.3

ICD-10 Finland

Other chest pain

1.5

6.1

175

1186

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

6.1

668

5640

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

6.1

117

721

N03AX09

ATC

lamotrigine; oral

2.2

6.1

227

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.8

6.1

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.1

6.1

R06AE09

ATC

levocetirizine; oral

1.5

6.1

178

1213

I50

ICD-10 Finland

Heart failure

1.9

6.1

385

TPX15

NOMESCO Finland

Removal of vascular injection port

12.6

6.1

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.4

6.1

164

A10AE04

ATC

insulin glargine; parenteral

1.5

6.0

174

1182

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

6.0

207

1458

A05AA02

ATC

ursodeoxycholic acid; oral

3.2

6.0

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.5

6.0

B05DB

ATC

Hypertonic solutions

5.2

6.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

6.0

102

609

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

6.0

511

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.1

6.0

282

RS220, ,

NOMESCO Finland

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001604) Monocytes [#/volume] in Blood

1553

6987

8.37

319.55

11.9

5.3

0.60

0.62

e9/l

1.32

1414

5939

(3006315) Basophils [#/volume] in Blood

1553

7013

8.32

317.35

11.9

5.3

0.04

e9/l

0.01

1414

5967

(3022096) Basophils/100 leukocytes in Blood

1467

6318

7.23

315.13

12.0

5.5

0.69

0.68

0.22

1406

5790

(3019069) Monocytes/100 leukocytes in Blood

1489

6544

7.37

311.06

12.7

5.8

9.32

8.88

5.33

1428

6008

(3019198) Lymphocytes [#/volume] in Blood

1559

7142

8.27

310.93

12.0

5.4

1.86

1.81

e9/l

0.72

1435

6201

(3006504) Eosinophils/100 leukocytes in Blood

1485

6517

7.32

310.52

12.1

5.5

2.88

3.00

1.05

1423

5980

(3047189) Immunofixation for 24 hour Urine

378

96.54

307.65

1.9

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1184

478

66.28

307.65

7.1

1.3

69.06

45.58

mg/l

4.64

941

386

(3045142) Bone marrow Pathology biopsy report

251

101

28.57

307.65

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1173

463

66.76

307.65

6.9

1.3

6.26

1.27

ratio

4.39

102

(3007164) IgA [Mass/volume] in Serum or Plasma

1001

2270

8.37

307.65

4.1

1.3

3.39

2.75

g/l

3.74

833

1262

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1018

1521

13.56

307.65

5.6

2.5

227.73

237.55

u/l

1.75

975

1404

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

560

431

18.15

307.65

7.9

1.3

0.00

g/l

-0.00

539

393

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

911

633

27.22

307.65

6.9

1.2

3.74

3.76

g/l

0.07

851

554

(3027945) Reticulocytes/100 erythrocytes in Blood

917

1913

8.47

307.65

3.6

2.1

1.72

1.76

0.63

844

1658

(40760892) CBC W Ordered Manual Differential panel - Blood

1523

6501

8.38

307.65

13.0

5.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1433

1124

51.99

307.65

7.9

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

575

439

18.50

307.65

7.7

1.3

0.01

0.00

g/l

1.98

540

395

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

655

506

19.43

307.65

7.2

1.3

38.57

37.47

g/l

3.00

590

427

(3020630) Protein [Mass/volume] in Serum or Plasma

1431

1286

44.75

307.65

8.3

1.4

69.55

66.59

g/l

23.69

1360

1141

(3023520) Reticulocytes [#/volume] in Blood

772

1442

8.44

307.65

3.6

2.1

65.78

67.80

e9/l

0.71

591

1098

(21494890) Protein electrophoresis panel - 24 hour Urine

610

132

68.24

307.65

2.7

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

525

184

39.34

307.65

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

899

692

24.19

307.65

4.6

1.3

3.28

1.15

g/l

18.18

802

629

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1182

477

66.11

307.65

7.1

1.3

53.55

34.01

mg/l

4.05

945

386

(3037756) Immunofixation for Serum or Plasma

1080

280

90.46

307.65

2.1

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

913

633

27.34

307.65

6.9

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

963

873

21.78

307.65

5.7

2.1

12.83

10.84

g/l

10.44

894

794

(3020876) Protein [Mass/time] in 24 hour Urine

336

147

27.67

307.65

2.8

2.0

0.91

1.76

g/24h

1.06

170

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

860

587

26.37

307.65

7.1

1.3

2.60

3.02

g/l

15.29

800

508

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

840

595

24.90

307.65

7.0

1.3

11.88

10.48

g/l

6.08

773

515

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

913

633

27.34

307.65

6.9

1.2

6.95

7.55

g/l

11.52

850

553

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

963

515

37.66

307.65

7.0

1.3

5.30

0.12

g/l

81.93

759

441

(40760888) Immunoglobulin light chains.free panel - Serum

993

350

59.65

307.65

6.5

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

655

468

21.05

307.65

7.4

1.3

0.18

0.00

g/l

6.21

612

423

(3013115) Eosinophils [#/volume] in Blood

1566

7262

8.27

306.16

12.5

5.4

0.19

0.21

e9/l

3.97

1435

6256

(3002030) Lymphocytes/100 leukocytes in Blood

1493

6656

7.27

304.23

12.4

5.7

27.79

26.51

3.74

1434

6134

(3018010) Neutrophils/100 leukocytes in Blood

1480

6594

7.07

300.22

11.6

5.5

56.48

58.32

6.24

1416

6075

(3013650) Neutrophils [#/volume] in Blood by Automated count

1587

7730

8.13

284.57

18.4

6.0

3.95

4.40

e9/l

12.08

1460

6598

(3017704) Immunofixation for Urine

201

26.08

284.09

1.8

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1578

7673

7.93

282.62

15.9

5.5

1.22

1.21

mmol/l

0.85

1330

6491

(21494434) Karyotype in Bone marrow

214

109

22.05

281.89

1.1

1.2

—

(3018418) pH of Serum or Plasma

1164

4409

5.38

281.12

10.9

3.3

7.39

7.40

1.48

291

752

(3003458) Phosphate [Moles/volume] in Serum or Plasma

730

1948

5.52

268.29

8.7

5.1

1.07

1.03

mmol/l

3.60

686

1779

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

134

131.19

265.83

3.1

1.1

—

(4035726) Immunohistochemistry procedure

315

355

10.48

262.36

1.5

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1384

6331

5.62

255.86

8.3

3.7

33.99

35.18

g/l

11.52

1310

5780

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1452

6923

5.98

254.42

13.4

5.0

1.22

1.21

mmol/l

3.43

1393

6126

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

722

2071

5.06

239.78

4.1

2.6

22.21

22.49

0.20

646

1724

(3004789) Transferrin [Mass/volume] in Serum or Plasma

743

2214

4.92

234.62

3.9

2.5

2.18

2.28

g/l

4.51

712

2024

(3022948) Iron [Moles/volume] in Serum or Plasma

775

2412

4.79

231.06

3.9

2.5

11.96

12.75

umol/l

2.37

746

2216

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

414

746

6.85

229.45

2.0

1.6

1.43

1.51

g/l

0.75

348

637

(3026493) Urate [Moles/volume] in Serum or Plasma

1045

4119

4.50

226.58

4.9

2.5

2320.58

7486.04

umol/l

4.68

958

3498

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

115

111.36

224.40

3.3

1.1

—

(3036603) Volume of Urine

166

22.68

223.09

1.8

1.4

1870.37

1886.64

0.06

166

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1413

7130

5.07

214.93

9.3

3.6

11.04

12.23

umol/l

2.98

1370

6657

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

103

90.80

196.24

1.1

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

264

349

8.65

192.32

1.7

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

450

1049

5.34

187.12

1.8

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

436

1009

5.34

182.52

1.7

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

478

1227

4.90

176.38

1.8

1.5

—

(3000012) Reticulocyte production index

208

226

10.24

176.22

2.7

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1050

4813

3.71

169.04

4.8

2.1

2.34

2.35

mmol/l

2.41

930

3985

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1170

5769

3.77

167.72

4.7

2.8

184.88

139.49

ug/l

4.86

1091

5215

(3017181) Myelocytes/100 leukocytes in Blood

435

1098

4.86

162.91

6.5

3.7

0.80

0.82

0.06

209

286

(3021879) Hepatitis B virus core Ab [Presence] in Serum

309

582

6.17

161.10

1.4

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

639

2181

3.94

159.31

4.1

2.4

0.80

0.82

mmol/l

5.23

595

1991

(3044927) Protein electrophoresis panel - Urine

190

210

9.96

158.64

1.4

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

924

4025

3.57

158.54

2.9

2.3

3.02

2.97

mg/l

0.18

809

3393

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

156

243.01

153.64

1.2

1.0

—

(3023368) Bacteria identified in Blood by Culture

934

4227

3.43

148.24

6.8

3.9

—

(3037522) Nuclear Ab [Titer] in Serum

554

1796

3.97

147.40

1.4

1.3

604.30

582.02

titre

0.08

121

425

(3048879) Bone marrow aspiration report

30.95

147.37

1.4

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

403

1059

4.58

142.16

6.6

3.7

0.13

0.06

1.11

178

247

(3002179) Metamyelocytes/100 leukocytes in Blood

392

1014

4.63

141.01

6.3

3.6

0.58

0.67

0.35

178

256

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

429

1248

4.17

131.52

5.2

3.6

105.34

93.36

ng/l

1.51

368

1047

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1653

11178

5.27

130.99

15.7

5.3

82.32

76.79

u/l

3.48

1618

10281

(3021589) Normoblasts [#/volume] in Blood

1145

6182

3.21

129.27

21.2

8.8

0.01

0.00

e9/l

0.44

984

5006

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

209

330

7.01

128.85

3.8

2.5

1.85

1.69

mg/l

1.30

192

284

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

57.57

127.72

1.3

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

222

380

6.50

126.55

2.0

1.6

0.22

0.23

g/l

0.67

212

358

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

224

387

6.44

126.51

1.9

1.6

1.18

1.16

g/l

0.20

214

363

(3025159) Blasts/100 leukocytes in Blood

371

1014

4.32

123.20

6.8

3.8

0.95

0.07

0.75

144

208

(3037121) Protein [Mass/volume] in Urine

246

494

5.59

118.48

2.1

2.6

0.32

0.26

g/l

0.57

121

159

(3020779) Urea [Moles/volume] in Serum or Plasma

435

1375

3.82

117.51

10.5

6.4

12.42

11.35

mmol/l

1.90

415

1300

(3009445) Proteinase 3 Ab [Units/volume] in Serum

288

691

4.75

112.51

1.2

1.6

1.38

22.52

u/ml

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

637

2630

3.16

111.74

2.4

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

178

8.75

111.01

6.0

5.5

23603.48

681.04

iu/ml

0.48

(3021960) Folate [Moles/volume] in Serum or Plasma

846

4133

2.92

109.05

2.1

1.5

20.85

20.38

nmol/l

0.35

759

3416

(3002582) Erythrocytes [#/volume] in Urine

892

4515

2.87

107.06

4.8

3.1

31.38

79.22

e6/l

2.41

740

3462

(40758558) Short blood count panel - Blood

712

3213

2.97

105.62

12.0

4.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

591

2411

3.13

104.88

3.1

1.9

30.18

29.99

0.28

572

2320

(3030467) Casts [#/volume] in Urine by Automated count

831

4116

2.84

102.96

4.7

3.0

0.49

0.50

e6/l

0.07

685

3129

(3013826) Glucose [Moles/volume] in Serum or Plasma

1390

9019

3.13

102.26

9.3

4.3

6.71

6.91

mmol/l

3.05

1346

8423

(3018095) Leukocytes [#/volume] in Urine

973

5242

2.79

102.22

5.7

3.5

66.35

123.57

e6/l

2.56

768

3720

(3013707) Erythrocyte sedimentation rate by Westergren method

1582

11083

3.84

102.00

8.4

4.2

30.33

12.99

mm/h

100.88

1498

10147

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

164

274

6.47

95.19

1.4

1.2

50.12

20.16

u/l

4.78

158

235

(36304419) Bacteria [Presence] in Urine

794

3980

2.73

94.16

4.6

3.0

—

(3033658) Prothrombin time (PT) actual/Normal

713

3384

2.79

94.11

6.0

3.5

84.90

84.30

0.23

692

3282

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1055

6115

2.67

92.84

3.2

2.2

80.42

79.07

nmol/l

0.81

952

5278

(3000850) Epithelial cells [#/volume] in Urine

680

3175

2.80

92.31

3.6

2.4

4.05

5.06

e6/l

1.87

622

2819

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

475

1846

3.11

90.05

2.2

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

474

1851

3.09

89.00

2.1

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

281

787

4.03

88.71

2.3

1.4

3.57

2.74

ug/l

1.46

228

586

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

624

2835

2.81

88.69

4.1

2.2

2.48

2.45

mmol/l

9.05

553

2421

(3022217) INR in Platelet poor plasma by Coagulation assay

1220

7698

2.70

88.60

23.2

19.6

1.29

1.40

inr

3.70

395

2186

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

231

569

4.49

86.47

2.1

1.8

38.45

38.74

u/l

0.06

194

473

(3044640) Blood type and Crossmatch panel - Blood

788

4083

2.61

85.47

4.3

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1041

6155

2.57

85.40

4.0

2.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

962

5496

2.55

84.69

4.0

3.1

2218.65

1675.37

ng/l

1.61

873

4741

(3026782) Osmolality of Urine

647

3060

2.71

84.29

4.2

2.8

504.59

538.45

mosm/kgh2o

4.64

574

2584

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

391

1412

3.24

83.43

3.6

2.2

8.69

8.54

umol/l

0.04

332

1217

(21491868) Cryoglobulin [Mass/volume] in Serum

14.05

83.04

1.4

1.3

1.56

0.07

g/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1137

7076

2.56

82.56

2.7

2.1

95.64

93.73

pmol/l

0.65

669

3580

(3019309) Folate [Moles/volume] in Red Blood Cells

708

3563

2.59

80.59

2.1

1.8

1268.76

1156.44

nmol/l

1.92

555

2644

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

319

1038

3.50

80.34

2.0

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

120

172

7.39

80.25

4.1

3.1

1.52

1.48

0.04

103

142

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

126

8.59

78.79

2.6

2.4

141.14

282.33

u/ml

—

(40768804) Tissue Pathology biopsy report

802

4329

2.50

78.07

2.5

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

214

542

4.33

77.01

1.5

1.6

75.56

270.00

titre

—

(3011412) CD3 cells [#/volume] in Blood

12.11

76.87

2.7

2.3

1.37

1.16

e9/l

0.64

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

346

1231

3.22

75.12

10.7

3.1

1.22

1.23

mmol/l

0.13

333

1039

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

160

341

5.04

71.16

2.2

2.0

12.12

12.27

mg/l

0.07

143

310

(3031040) Bacteria [#/volume] in Urine by Automated count

1385

9856

2.58

69.46

6.6

4.6

692.75

2442.48

e6/l

1.19

153

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

195

501

4.23

68.64

3.7

2.7

0.28

0.35

u/ml

2.67

114

308

(3000991) Gas panel - Venous blood

334

1234

3.08

67.51

10.4

6.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

126

229

5.83

66.80

4.3

3.3

56.18

58.41

0.96

126

229

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

145.37

66.38

5.6

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

175

429

4.40

65.44

1.3

1.4

13.66

17.56

iu/ml

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1415

10324

2.54

64.58

6.7

4.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

141

293

5.12

64.48

2.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

10.36

64.02

1.7

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

10.36

64.02

1.7

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

321

1197

3.03

63.59

2.2

1.8

349.42

360.34

nmol/l

0.39

296

1068

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

137

282

5.16

63.32

2.3

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

215

631

3.72

62.65

2.2

1.7

2.74

1.46

ug/l

0.86

188

547

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

12.62

60.92

2.5

2.7

—

(3042936) Bacteria identified in Isolate by Culture

450

2048

2.58

60.57

2.3

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

602

3130

2.36

60.52

3.8

2.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

108

186

6.10

60.47

1.5

1.8

0.57

1.01

g/l

2.61

149

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

143

318

4.79

60.32

2.9

2.2

3.76

3.45

g/l

1.37

138

296

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

108

188

6.04

59.81

1.5

1.3

—

(3002256) Pathology report gross observation

274

978

3.11

58.30

1.5

1.1

—

(1616796) Gas panel - Central venous blood

143

330

4.61

57.60

5.3

3.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

123

251

5.18

57.35

4.3

3.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

481

2318

2.45

56.86

4.1

2.8

2.22

2.48

e6/l

0.25

273

1280

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

242

819

3.25

56.25

9.0

6.6

24.33

24.79

mmol/l

1.11

237

810

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

109

204

5.61

55.92

2.4

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

293

1111

2.94

55.91

2.3

1.9

0.19

0.20

g/l

1.13

260

1000

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

104

188

5.80

55.36

1.1

—

(3026008) Bacteria identified in Urine by Culture

810

4906

2.15

54.87

4.1

3.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

502

2505

2.37

54.60

3.8

2.7

1.07

1.39

e6/l

0.72

297

1456

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

476

2339

2.39

53.47

1.4

1.3

57.28

41.26

iu/ml

0.88

152

724

(3027135) IgG subclass 1 [Mass/volume] in Serum

120

7.01

52.41

1.5

1.4

7.85

6.99

g/l

0.58

(3024139) IgG subclass 3 [Mass/volume] in Serum

120

7.01

52.41

1.5

1.4

0.49

0.39

g/l

0.50

(3028192) IgG subclass 2 [Mass/volume] in Serum

120

7.01

52.41

1.5

1.4

2.72

3.01

g/l

0.45

(4062490) Immunoglobulin typing, IgG

120

7.01

52.41

1.6

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

76.26

52.31

2.0

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

162

443

3.91

52.04

1.8

—

(40768446) Kidney Pathology biopsy report

11.83

51.75

1.3

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

124

281

4.66

51.01

1.2

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

174

507

3.68

50.98

1.4

1.2

3.76

0.88

u/ml

0.59

(3012544) pH of Venous blood

365

1638

2.53

49.65

5.9

3.4

7.39

7.37

0.33

(3002032) Base excess in Venous blood by calculation

353

1563

2.55

49.38

6.2

3.3

1.66

2.01

mmol/l

0.88

305

1314

(3021447) Carbon dioxide [Partial pressure] in Venous blood

354

1571

2.55

49.27

6.1

3.3

5.91

5.82

kpa

0.86

340

1512

(40768797) Stomach Pathology biopsy report

416

1992

2.40

49.06

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

16.75

48.81

2.0

3.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

161

5.82

48.39

1.5

1.4

101.08

106.25

u/ml

0.21

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

562

3072

2.19

48.23

2.1

1.6

1.40

1.33

mg/l

0.21

469

2386

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

10.67

47.43

3.2

1.6

768.37

425.91

e6/l

1.20

(3017354) Segmented neutrophils/100 leukocytes in Blood

127

6.45

47.30

4.6

2.8

53.43

58.11

0.83

102

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

700

4190

2.07

47.14

4.0

2.6

32.56

36.36

u/l

0.75

652

3927

(3035350) Ketones [Presence] in Urine by Test strip

1051

7279

2.02

46.97

5.4

3.8

0.00

0.01

estimate

1.34

281

1362

(3012501) Base excess in Blood by calculation

130

326

4.21

46.95

6.5

4.5

2.63

2.80

mmol/l

0.27

215

(3013290) Carbon dioxide [Partial pressure] in Blood

130

327

4.20

46.75

6.5

4.5

4.95

5.07

kpa

0.79

125

319

(3027315) Oxygen [Partial pressure] in Blood

130

329

4.17

46.37

6.5

4.5

8.30

8.32

kpa

0.04

125

320

(3021601) Nitrite [Presence] in Urine by Test strip

1047

7265

2.01

46.27

7.2

5.1

0.00

estimate

-0.00

264

1238

(3009261) Glucose [Presence] in Urine by Test strip

1057

7360

2.01

46.23

5.4

3.8

0.00

0.01

estimate

1.08

256

1196

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1713

14503

3.26

45.44

37.4

14.2

24.97

24.93

mg/l

0.01

1598

11438

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

113

263

4.51

44.92

1.2

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

340

1548

2.46

44.45

5.6

3.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

501

2702

2.17

43.85

1.3

1.2

0.87

1.89

u/ml

3.18

107

680

(3010421) pH of Blood

139

387

3.80

43.40

6.9

4.3

7.42

0.00

126

348

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

155

465

3.55

43.33

1.5

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

952

6491

1.95

43.14

5.4

4.1

49.63

98.36

ng/l

0.95

791

4928

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

807

5212

1.97

42.81

2.5

2.1

233.26

229.12

u/l

0.03

775

4853

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

226

4.67

42.14

1.6

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

142

413

3.64

41.57

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

138

394

3.70

41.52

2.2

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

176

5.14

40.88

2.0

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

136

5.78

40.82

1.8

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

113

284

4.17

40.63

1.6

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

139

5.66

39.89

1.2

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

369

1825

2.27

39.55

7.7

6.1

11.38

11.43

kpa

0.07

356

1732

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

369

1825

2.27

39.55

7.7

6.1

5.08

kpa

0.01

356

1734

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

726

4617

1.94

39.47

3.0

2.3

59.22

61.09

u/l

0.38

673

4217

(3022145) Colonoscopy Study observation

302

1379

2.42

38.86

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

292

1315

2.45

38.73

8.5

5.8

1.35

1.49

mmol/l

1.13

286

1282

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

193

4.79

38.55

2.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

193

4.79

38.55

2.3

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

210

4.61

38.35

1.2

—

(3015736) pH of Urine

857

5795

1.89

38.30

4.5

3.5

5.50

5.74

0.84

244

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

203

4.66

38.09

1.6

1.3

—

(3003396) Base excess in Arterial blood by calculation

364

1817

2.25

38.02

7.8

6.2

1.21

1.23

mmol/l

0.03

311

1421

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

426

2270

2.14

37.74

1.3

1.2

19.49

13.78

u/ml

0.44

118

821

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

172

4.94

36.94

1.6

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

119

333

3.75

36.83

4.1

2.4

14.52

16.33

4.27

177

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

111

296

3.92

36.79

2.2

1.8

2239.71

33.14

u/ml

0.69

235

(3002385) Erythrocyte distribution width [Ratio]

1492

12215

2.11

36.11

43.3

16.5

15.38

15.35

0.08

1487

11917

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1142

8561

1.86

35.83

3.8

3.0

62.88

50.53

u/l

2.93

1045

7745

(3036489) Thrombin time

139

439

3.34

35.76

2.8

1.8

22.18

21.19

1.30

130

386

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

556

3328

1.96

35.40

5.5

4.1

287.16

510.88

ng/l

0.90

496

2839

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

175

4.79

35.24

1.4

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

183

4.70

35.23

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

149

504

3.13

34.21

3.0

—

(3016502) Oxygen saturation in Arterial blood

331

1654

2.22

34.19

8.2

6.3

94.43

94.91

0.50

321

1584

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

7.97

33.70

2.6

2.3

38.91

44.94

0.87

(3002173) Hemoglobin [Mass/volume] in Arterial blood

307

1499

2.25

33.50

8.6

6.7

114.38

122.14

g/l

9.23

302

1460

(40768443) Skin Pathology biopsy report

162

584

2.94

33.26

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

130

413

3.31

33.11

3.6

3.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

231

1003

2.49

32.90

2.1

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

338

1728

2.17

32.87

2.1

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

202

824

2.63

32.76

1.3

32.87

59.20

au/ml

—

(3012516) Albumin [Mass/volume] in Urine

789

5405

1.80

32.07

5.1

3.2

5928.11

181.21

mg/l

20.48

601

3431

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

967

7035

1.78

31.97

2.8

2.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

221

955

2.49

31.76

1.7

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

254

1172

2.35

31.56

2.5

2.1

33.39

33.86

u/l

0.07

206

971

(3048929) Epstein Barr virus Ab [Presence] in Serum

227

4.07

31.35

1.3

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

184

4.44

31.33

1.7

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

215

923

2.50

31.32

2.6

2.4

26.79

22.63

au/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

166

4.60

30.76

1.4

1.1

289.32

259.10

u/ml

0.30

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

6.86

30.21

2.4

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

7.01

30.18

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

104

5.62

29.99

1.9

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

116

365

3.32

29.98

1.4

1.2

3.03

3.41

u/ml

0.15

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1358

11026

1.86

29.97

4.5

3.8

14.99

15.03

pmol/l

0.26

1236

9810

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

159

601

2.80

29.86

2.9

2.2

981.46

915.48

ug/l

0.05

147

561

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

123

403

3.20

29.76

1.6

0.26

6.95

iu/ml

0.49

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

120

389

3.23

29.55

1.4

1.2

25.41

55.01

u/ml

0.84

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

116

370

3.28

29.32

1.4

1.2

3.53

3.85

u/ml

0.12

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

103

305

3.52

29.27

1.4

1.2

5.16

10.42

u/ml

0.40

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

9.37

29.20

3.5

2.2

—

(40761536) Microorganisms panel - Urine sediment

242

1131

2.31

29.08

6.9

3.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

111

347

3.34

28.98

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

111

347

3.34

28.98

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

108

334

3.37

28.69

1.3

1.1

217.14

100.95

titre

—

(3010838) Calcium [Moles/time] in 24 hour Urine

261

3.70

28.63

1.9

2.0

4.38

4.91

mmol/24h

0.74

221

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

318

1683

2.07

27.90

3.4

3.1

311.03

229.68

ng/l

1.72

287

1551

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

4.89

27.47

5.6

3.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

148

4.59

27.45

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

5.81

27.32

1.9

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

186

800

2.47

26.87

9.9

8.5

—

(3009343) pH of Capillary blood

218

1018

2.29

26.14

4.9

3.5

7.41

0.13

125

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

212

979

2.32

26.09

4.9

3.5

2.34

1.92

mmol/l

0.79

161

700

(3012441) Differential panel - Pleural fluid

142

4.56

26.04

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

189

4.04

26.02

1.6

1.5

29.47

27.53

g/l

0.51

167

(40768800) Prostate Pathology biopsy report

5.85

25.91

1.1

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

219

1035

2.26

25.50

4.9

3.5

5.17

5.18

kpa

0.02

207

969

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

118

4.86

25.11

1.4

1.3

171.01

286.66

u/l

1.79

113

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

275

3.43

25.06

1.6

1.7

—

(4212803) Bone marrow aspirate examination

39.40

24.91

1.1

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

115

4.90

24.88

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

161

4.21

24.68

1.3

1.2

48.34

65.30

u/ml

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

5.22

24.35

2.8

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

5.22

24.35

2.8

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

5.22

24.35

2.8

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

114

4.85

24.16

2.8

1.3

—

(40768806) Pleura Pathology biopsy report

122

4.70

24.13

1.6

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

186

3.93

24.12

4.8

6.3

11.65

12.37

mg/l

0.71

173

(3021901) Oxygen saturation in Capillary blood

318

3.20

24.08

3.8

2.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1562

13573

1.94

24.02

5.6

4.6

1.98

2.12

mu/l

0.80

1433

12141

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

7.51

23.79

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1574

13724

1.95

23.78

33.5

13.3

68.18

73.68

ml/min/173m2

16.56

1428

11045

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

124

4.63

23.67

2.8

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1723

15550

2.45

23.61

39.7

17.3

139.00

139.76

mmol/l

25.83

1710

15096

(3017732) Neutrophils [#/volume] in Blood

197

920

2.28

23.54

3.9

3.1

4.60

5.55

e9/l

0.67

136

672

(3023103) Potassium [Moles/volume] in Serum or Plasma

1725

15586

2.45

23.39

41.2

17.5

4.01

4.00

mmol/l

0.35

1711

15105

(3024354) Oxygen [Partial pressure] in Venous blood

253

1309

2.08

23.34

4.8

2.8

4.77

4.52

kpa

0.82

241

1256

(3014148) Varicella zoster virus Ab [Titer] in Serum

5.16

23.13

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

259

3.39

23.11

1.3

1.2

34.18

55.20

u/ml

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

6.20

22.87

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

101

4.96

22.55

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

755

5487

1.63

22.28

4.0

3.2

6.57

7.30

mmol/l

5.62

642

4554

(3003694) ABO and Rh group [Type] in Blood

498

3247

1.73

22.27

1.5

1.3

—

(3042631) Mycobacterium sp identified in Specimen

193

3.73

22.13

3.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1716

15562

2.31

21.46

22.0

9.4

24.52

25.10

u/l

0.60

1691

14787

(3000570) Elastase.pancreatic [Mass/mass] in Stool

105

379

2.88

21.44

1.4

262.05

292.14

ug/g

0.75

235

(3011397) Hemoglobin [Presence] in Urine by Test strip

537

3611

1.68

21.27

4.6

3.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

144

4.13

21.21

1.8

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

144

4.13

21.21

1.8

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

165

754

2.30

20.70

1.5

1.2

197.16

245.98

u/ml

0.40

157

689

(3044889) 12 lead EKG panel

1289

10774

1.64

20.59

5.6

4.2

—

(40761511) CBC panel - Blood by Automated count

1664

14958

2.06

20.56

31.1

13.9

—

(3049717) Cytology report of Urine Cyto stain

129

529

2.55

20.54

2.7

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

176

3.73

20.32

1.0

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

230

1209

2.03

20.20

3.7

2.4

44.83

62.54

ml/min/173m2

13.33

147

494

(3048689) Calprotectin [Mass/mass] in Stool

258

1417

1.95

19.99

2.0

2.1

120.74

169.42

ug/g

2.06

209

1117

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

104

4.61

19.90

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

105

4.57

19.67

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

105

4.57

19.67

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

105

4.57

19.67

1.0

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

100

369

2.81

19.61

3.4

2.1

118.56

131.97

g/l

5.70

273

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.09

19.54

1.7

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

107

4.48

19.22

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

107

4.48

19.22

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

107

4.48

19.22

1.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.45

19.04

1.7

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.73

19.01

1.7

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

538

3707

1.63

19.00

5.5

3.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

6.29

18.49

3.1

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

6.29

18.49

3.1

1.1

—

(3019060) Gas panel - Arterial blood

211

1109

2.02

18.48

4.5

4.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.15

18.39

4.1

4.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

4.90

18.29

1.3

1.1

51.83

37.42

mg/l

1.13

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.38

18.28

1.8

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

235

3.19

18.20

1.3

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

310

2.89

18.20

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

167

3.62

17.98

1.7

1.5

973.05

1737.74

e6/l

1.31

119

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

302

2.90

17.88

1.5

1.4

340.38

615.83

e6/l

0.32

251

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

4.90

17.81

1.2

1.0

346.21

272.33

mg/l

1.21

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

303

2.89

17.77

1.4

1.3

14.39

35.58

e6/l

0.50

240

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

155

3.69

17.64

1.6

1.7

16.12

26.80

u/ml

0.71

140

(3019225) pH of Specimen

275

1604

1.84

17.59

11.0

3.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

756

5718

1.54

17.59

5.0

3.8

25.81

8.46

mg/mmol

7.19

537

3594

(3000494) Fungus identified in Specimen by Culture

281

1657

1.82

17.34

1.7

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.95

17.12

1.2

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

22.08

16.86

3.0

1.9

70.63

196.00

e6/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.77

16.85

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

313

2.80

16.75

1.3

1.2

3.82

3.97

mmol/l

0.78

287

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

5.50

16.68

2.2

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

1733

16031

2.17

16.44

53.1

20.8

37.29

39.91

52.73

1631

14640

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

14.40

16.32

1.7

3.9

—

(3010813) Leukocytes [#/volume] in Blood

1733

16038

2.16

16.31

53.0

20.7

6.88

6.81

e9/l

0.59

1713

15405

(3007461) Platelets [#/volume] in Blood

1733

16040

2.16

16.27

53.0

20.7

242.33

241.53

e9/l

0.15

1716

15478

(3024731) MCV [Entitic volume]

1733

16042

2.16

16.23

52.8

20.7

93.70

91.67

40.93

1724

15694

(3035941) MCH [Entitic mass]

1733

16043

2.16

16.21

52.7

20.6

30.88

30.49

12.16

1723

15696

(3026361) Erythrocytes [#/volume] in Blood

1733

16044

2.16

16.19

52.9

20.7

4.07

4.46

e12/l

132.37

1713

15410

(3028308) Erythrocytes [#/volume] in Pleural fluid

150

3.61

16.18

1.7

1.5

13088.27

81883.55

e6/l

0.92

(3000963) Hemoglobin [Mass/volume] in Blood

1733

16046

2.16

16.15

53.4

20.9

123.92

135.34

g/l

140.45

1722

15702

(3003181) Sodium [Moles/volume] in Urine

281

2.85

16.02

1.2

1.3

55.69

63.17

mmol/l

1.17

224

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

531

3774

1.57

15.98

2.0

1.7

38389066.53

41833481.47

pmol/l

0.03

422

3055

(3025941) Bacteria identified in Stool by Culture

146

707

2.16

15.86

1.4

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.69

15.66

1.7

1.4

4.25

7.22

u/l

0.61

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

107

458

2.42

15.56

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

184

980

1.97

15.46

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

4.26

15.08

1.2

1.1

—

(3013512) EKG study

650

4882

1.51

14.99

5.2

4.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

195

1075

1.91

14.79

4.7

3.0

117.79

130.69

g/l

13.21

188

1041

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

4.40

14.53

1.5

1.4

5.21

6.35

u/l

0.67

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

167

880

1.99

14.45

2.7

2.5

—

(3023419) Bacteria identified in Sputum by Culture

280

2.75

14.43

3.6

2.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

164

3.30

14.14

1.2

2.04

2.15

u/ml

0.07

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

6.28

13.75

3.7

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

6.28

13.75

3.7

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

6.28

13.75

3.7

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

721

5608

1.47

13.64

6.1

4.0

—

(3045788) Cell count panel - Pleural fluid

134

3.49

13.49

1.8

1.5

—

(3035880) pH of Pleural fluid

4.31

13.39

1.2

1.3

—

(3021788) Differential panel - Synovial fluid

299

2.61

13.22

1.5

—

(3051651) Icteric interference index of Serum or Plasma

4.67

13.07

3.2

3.9

—

(40765096) Chromosome analysis panel by Banding

11.63

12.80

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

310

2.55

12.79

3.1

2.4

32.61

33.32

umol/l

0.10

275

(3029937) Albumin [Presence] in Urine by Test strip

538

4001

1.48

12.56

6.6

4.1

0.00

estimate

0.50

243

1193

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.85

12.27

3.0

2.3

912.00

6647.80

u/ml

—

(40768793) Breast Pathology biopsy report

4.52

12.14

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

132

681

2.01

12.12

3.2

2.8

4.14

4.43

pmol/l

2.68

121

573

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

175

3.03

12.11

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

110

3.60

12.02

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

160

886

1.88

11.94

4.9

2.9

25.83

25.20

mmol/l

1.07

155

851

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

10.59

11.76

3.6

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

795

6422

1.42

11.72

5.2

4.0

2.41

2.09

ug/l

1.03

692

5707

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

4.38

11.70

1.1

0.93

1.14

u/l

2.24

(3004616) Nuclear Ab [Presence] in Serum

196

2.86

11.59

1.6

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

145

787

1.91

11.50

2.3

2.1

11.89

14.63

nmol/l

2.88

117

687

(40768795) Lymph node Pathology biopsy report

10.11

11.49

1.5

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.42

11.35

1.5

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

5.42

11.35

1.0

1.1

1594.59

1660.66

miu/ml

0.08

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

150

3.12

11.32

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.84

11.21

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

184

1085

1.77

11.19

6.1

6.3

25.08

24.56

mmol/l

0.73

176

1036

(3023487) Leukocytes [#/volume] in Peritoneal fluid

5.77

11.01

2.4

2.3

833.07

1137.40

e6/l

0.16

(3044290) Cell count panel - Cerebral spinal fluid

272

2.52

10.97

1.5

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.68

10.95

1.3

2.4

56.47

64.69

mg/l

0.32

(3051611) Lipemic interference index of Serum or Plasma

138

3.17

10.87

3.2

3.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

412

2.22

10.86

1.8

1.6

18807.71

14797.59

e6/l

0.30

302

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1551

14234

1.54

10.61

7.4

6.6

40.86

41.00

mmol/mol

0.23

1430

12997

(3016018) Differential panel - Cerebral spinal fluid

130

3.20

10.58

1.6

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

5.17

10.32

1.4

1.6

0.33

0.38

ug/l

0.16

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

127

3.20

10.31

1.5

1.6

—

2192.00

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

159

2.94

10.27

1.1

—

(3004451) EKG impression Narrative

3.68

10.26

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

10.09

10.01

1.7

1.1

—

(3024928) Oxygen saturation in Venous blood

337

2.28

9.85

3.9

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

200

1251

1.67

9.82

1.7

1.64

1.58

0.47

165

1040

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

312

2.33

9.82

1.7

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.41

9.80

1.3

69.87

60.98

0.53

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

159

2.88

9.67

1.2

3.14

7.32

u/ml

1.23

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

140

2.97

9.37

4.4

2.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

8.07

9.34

1.5

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

100

3.34

9.18

1.4

1.5

—

(3044941) Cell count panel - Synovial fluid

277

2.36

9.18

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

181

2.70

9.16

3.2

3.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

181

2.70

9.16

1.2

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

120

663

1.87

9.04

3.1

1.7

—

(3047181) Lactate [Moles/volume] in Blood

101

532

1.95

8.79

5.4

1.29

1.34

mmol/l

0.14

470

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.37

8.77

1.9

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

9.52

8.77

2.4

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

113

620

1.88

8.71

2.4

1.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

8.25

8.57

1.2

1.5

14.36

6.16

nmol/l

0.50

(3023410) Appearance of Cerebral spinal fluid

126

2.98

8.52

1.5

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

190

2.57

8.35

1.4

1.3

0.18

0.45

nmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

191

2.55

8.26

1.4

1.3

0.73

0.65

nmol/l

0.41

181

(3016750) Collection duration of Urine

103

3.14

8.11

2.0

1.9

505.90

492.34

min

0.26

(3022313) Gas panel - Capillary blood

126

733

1.77

8.05

5.1

3.6

—

(3006653) Thiamine [Moles/volume] in Blood

3.45

7.95

1.0

1.2

129.04

145.27

nmol/l

1.09

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

115

2.99

7.94

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

13.08

7.88

1.2

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

460

3574

1.38

7.85

3.1

2.7

0.83

0.74

ug/l

0.94

339

2471

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.22

7.67

1.9

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

169

2.58

7.61

1.9

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

18.43

7.60

1.5

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

8.06

7.59

1.4

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

108

612

1.81

7.54

5.7

3.9

24.68

24.64

mmol/l

0.05

554

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

213

2.38

7.48

1.5

1.4

69.63

68.55

0.08

133

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1576

14755

1.44

7.41

5.6

5.1

6.05

6.09

mmol/l

0.66

1425

13212

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

154

2.63

7.39

1.5

1.4

33.25

25.27

0.80

(3011985) Renin [Units/volume] in Plasma

196

2.43

7.37

1.4

92.35

53.64

mu/l

0.42

174

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

3.12

7.29

1.5

1.2

0.36

2.04

u/ml

0.89

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.26

7.24

2.6

2.0

4138.82

87710.54

e6/l

0.51

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

162

2.57

7.20

1.9

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

174

2.51

7.19

1.5

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

163

2.55

7.11

1.9

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

164

2.53

7.03

1.9

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

488

1.87

6.92

1.7

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.99

6.89

1.1

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

166

2.50

6.86

1.5

1.3

—

nmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

166

2.50

6.86

1.9

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3.36

6.83

1.8

1.4

1.70

4105.50

u/l

—

(3045424) Erythrocytes [Presence] in Urine

210

2.32

6.80

2.1

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.52

6.72

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.52

6.72

2.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.52

6.72

2.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

168

2.47

6.70

1.9

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

120

730

1.69

6.58

5.6

4.3

1.62

1.64

0.11

115

688

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

182

2.39

6.56

1.3

247.84

293.96

pmol/l

0.52

152

(3024869) Neuronal Ab [Presence] in Serum

5.34

6.46

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.34

6.46

2.2

2.5

—

(3033799) Differential panel - Peritoneal fluid

5.71

6.45

2.3

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

118

719

1.68

6.43

5.7

4.4

0.91

0.86

0.65

113

678

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.31

6.42

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

136

2.60

6.38

1.7

1.3

—

(3000492) Spirometry study

176

1186

1.53

6.34

1.6

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.60

6.32

1.9

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.36

6.28

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

+∞

6.25

1.8

0.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

6.25

1.0

0.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.31

6.14

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.31

6.14

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

235

1694

1.44

6.07

2.4

2.5

5.97

7.48

ug/l

0.82

206

1461

(40768441) Liver Pathology biopsy report

3.61

6.04

1.4

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

6.71

6.03

1.3

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

10.05

6.03

6.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

177

2.35

6.02

1.1

1.2

273.67

214.43

miu/ml

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

3.36

6.00

1.6

6.7

—

71.67

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

15.06

5.90

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

413

1.85

5.81

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

11.16

5.79

1.4

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.17

5.74

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1496

14031

1.34

5.72

4.6

4.3

1.27

1.28

mmol/l

0.15

1352

12558

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.93

5.71

3.8

3.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.20

5.70

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.12

5.69

1.8

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

416

1.84

5.68

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.54

5.63

1.0

1.2

—

(3020891) Body temperature

109

676

1.65

5.59

6.1

4.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

419

1.82

5.56

1.2

1.1

—

(3024471) HLA-A [Type]

5.39

5.53

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

165

2.33

5.53

1.1

1.0

1.53

1.56

g/l

0.11

141

(3029075) Extractable nuclear Ab panel - Serum

4.63

5.48

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.25

5.45

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

100

2.73

5.44

1.0

305.19

294.26

mg/l

0.25

(3018405) Lactate [Moles/volume] in Arterial blood

605

1.67

5.38

3.9

3.7

1.69

1.46

mmol/l

0.49

592

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

155

2.35

5.35

1.1

—

(4281824) Cell count and differential, peritoneal fluid

3.11

5.34

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.57

5.33

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.57

5.33

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.57

5.33

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.57

5.33

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

156

2.33

5.27

2.1

2.3

632.26

599.75

0.20

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1583

15019

1.36

5.25

5.7

5.5

2.43

2.60

mmol/l

10.78

1444

13629

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.03

5.25

1.1

1.0

80.50

82.23

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

4.60

5.17

1.7

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.36

5.17

1.1

1.07

1.08

ratio

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

7.37

5.14

1.4

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1534

14498

1.33

5.13

5.1

4.8

1.38

1.44

mmol/l

4.76

1390

13115

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1546

14629

1.33

5.12

5.1

4.9

4.28

4.47

mmol/l

10.12

1413

13335

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

613

5214

1.26

5.08

4.4

3.9

23.47

24.28

0.57

321

2579

(3014891) Appearance of Pleural fluid

6.35

5.08

1.3

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

8.37

5.06

1.2

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

10.04

5.02

1.6

2.6

—

(3042733) HLA Ab [Presence] in Serum

5.03

4.94

4.3

4.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

4.86

4.81

1.1

1.0

102.86

100.59

0.08

(3044007) Cell count panel - Peritoneal fluid

4.86

4.81

3.0

2.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.86

4.81

2.1

1.0

70.89

87.23

—

(3045414) Leukocytes [Presence] in Urine

102

648

1.61

4.79

2.7

1.9

—

(3008295) Osmolality of Serum or Plasma

138

2.34

4.76

1.6

1.5

272.96

274.24

mosm/kgh2o

0.09

100

(3013293) Extractable nuclear Ab [Presence] in Serum

5.74

4.75

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.44

4.74

1.2

2.11

9.63

ug/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

3.12

4.64

1.4

1.3

147.06

169.18

mmol/24h

0.60

(44816559) Phosphatidylethanol [Mass/volume] in Blood

219

2.03

4.63

1.4

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

147

2.27

4.58

1.8

35.38

24.97

u/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

14.05

4.57

3.7

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

364

1.79

4.53

1.6

1.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

10.04

4.52

2.5

3.6

—

(3024932) HLA-DR beta [Type]

4.84

4.50

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

551

1.63

4.41

1.3

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.67

4.37

3.1

1.5

—

(4200892) Spirometry reversibility

159

1135

1.44

4.35

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

211

2.01

4.33

3.7

5.5

7.11

7.49

mmol/l

0.33

174

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

184

2.09

4.32

1.9

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

8.92

4.28

1.5

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

8.92

4.28

1.5

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

8.92

4.28

1.5

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.85

4.23

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.14

4.21

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

6.95

4.16

1.1

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.02

4.10

1.1

1.8

93.81

69.71

nmol/24h

0.55

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.02

4.10

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.02

4.10

1.0

1.2

0.73

0.75

umol/24h

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

8.03

4.06

1.5

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

183

2.04

4.00

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.02

3.81

1.8

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.08

3.81

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.55

3.80

1.3

1.80

1.71

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.96

3.79

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.85

3.79

1.4

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

114

2.30

3.78

2.5

2.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

8.78

3.77

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

297

1.77

3.69

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

4.42

3.62

1.3

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

134

963

1.42

3.57

1.2

1.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

7.80

3.56

1.1

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.78

3.55

14.1

11.0

5.02

5.21

mmol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.56

3.43

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.56

3.43

2.1

2.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

4.09

3.39

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

484

1.57

3.39

2.8

2.2

175.79

92.13

ug/min

0.74

283

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.73

3.34

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.37

3.31

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.42

3.30

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.65

3.29

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.65

3.29

1.8

1.4

8.71

29.24

—

(3009871) Measles virus Ab [Titer] in Serum

3.65

3.29

1.8

1.5

—

(40761535) Cells panel - Urine sediment

182

1396

1.34

3.28

5.1

3.3

—

(3008898) HLA-B27 [Presence]

339

1.67

3.27

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.35

3.22

1.3

1.2

—

(3011648) Oxygen content in Venous blood

117

2.15

3.16

2.6

1.8

8.81

10.93

1.64

117

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.02

3.05

1.4

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.85

3.02

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

286

1.70

3.00

1.2

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

10.02

2.98

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.68

2.87

1.5

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

129

2.03

2.86

1.0

2.14

2.40

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

110

2.10

2.79

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.09

2.77

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

8.35

2.75

1.2

220.20

259.50

nmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

111

2.09

2.73

1.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

5.01

2.73

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

437

1.53

2.72

3.7

3.1

0.82

0.83

nmol/l

0.04

326

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.44

2.71

1.1

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

234

1.72

2.69

3.6

2.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.01

2.69

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

105

2.11

2.69

2.0

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

175

1.84

2.69

1.2

1.3

9.21

8.79

u/l

0.07

143

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

147

1.92

2.66

2.5

2.1

2.09

1.98

u/field

0.04

(3022621) pH of Urine by Test strip

141

1077

1.33

2.65

3.3

3.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

187

1486

1.29

2.65

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

2.80

2.64

1.5

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

176

1.83

2.64

1.5

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.26

2.61

3.1

1.6

3.25

2.51

u/field

0.14

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.47

2.54

1.2

1.0

—

(3025130) Human papilloma virus identified in Specimen

2.23

2.54

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.51

2.53

1.1

1.2

38.98

38.28

g/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.39

2.47

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.39

2.47

4.1

4.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.83

2.34

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

706

1.38

2.33

1.2

24.83

128.60

iu/ml

11.90

273

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.46

2.27

1.2

2.2

1.45

9.24

nmol/l

1.14

(3019977) pH of Arterial blood

2.08

2.27

2.2

2.4

7.40

7.43

0.71

(3003338) MCHC [Mass/volume]

1246

11865

1.15

2.18

46.8

18.9

329.41

332.00

g/l

18.04

1240

11752

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

462

4104

1.17

2.17

1.8

1.6

1.35

1.33

mmol/l

0.23

383

3376

(3032057) Clostridioides difficile [Presence] in Stool

2.79

2.13

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.37

2.12

1.1

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

548

1.40

2.10

1.4

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

153

1.78

2.08

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

5.01

2.07

1.4

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.71

2.07

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.33

2.05

1.2

1.1

108.20

75.92

ng/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.64

2.00

2.5

1.2

79.90

115.00

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.55

1.94

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.55

1.94

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

4.55

1.94

1.2

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.76

1.93

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

142

1.77

1.93

1.1

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.93

1.90

1.6

2.5

—

(3024263) Appearance of Synovial fluid

1.93

1.90

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

114

891

1.30

1.89

5.2

3.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.18

1.82

1.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.18

1.82

1.0

1.2

—

(3034426) Prothrombin time (PT)

2.58

1.80

1.2

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

154

1.70

1.76

1.8

1.2

331579.20

151251.84

e6/l

0.29

108

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.34

1.74

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.85

1.71

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.14

1.71

1.5

1.8

74.14

109.88

umol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.04

1.64

1.1

8.14

13.55

iu/ml

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.25

1.63

3.2

3.5

42.45

23.48

mu/l

0.23

(3016038) Potassium [Moles/volume] in Urine

120

1.76

1.62

1.0

1.2

28.33

34.54

mmol/l

0.72

104

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.70

1.58

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

2.04

1.54

1.9

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

407

0.63

1.53

1.2

1.7

5.23

2.94

mg/l

0.39

299

(3026480) Teichoate Ab [Titer] in Serum

3.34

1.52

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.34

1.52

1.0

1.1

2.02

1.88

umol/24h

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

514

0.67

1.52

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

324

1.43

1.52

2.2

1.4

0.90

0.79

nmol/l

0.40

259

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.86

1.50

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

2.16

1.50

1.0

1.4

0.27

0.24

nmol/l

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.87

1.50

1.8

1.5

0.92

0.93

g/l

0.10

(3019150) Specific gravity of Urine by Refractometry

379

3408

1.14

1.49

5.8

4.2

1.02

kg/l

0.17

534

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.44

1.48

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.37

1.45

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.13

1.44

1.0

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

286

1.44

1.7

5.31

3.90

iu/l

0.20

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.04

1.43

2.1

2.3

35668.50

41694.92

ug/l

0.56

(3015183) Erythrocyte sedimentation rate

2.26

1.40

5.2

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

468

1.34

1.38

6.2

4.3

—

(3014051) Protein [Presence] in Urine by Test strip

426

1.35

1.36

3.1

2.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

112

1.70

1.35

1.6

1.3

0.62

1.32

promille

1.25

(3022689) Creatine [Moles/volume] in Urine

2.13

1.33

3.3

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

368

0.65

1.32

1.8

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.50

1.30

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.36

1.29

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.78

1.28

1.4

1.8

—

(1002224) Polysomnography panel

405

1.34

1.27

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.29

1.27

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.05

1.27

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.40

1.24

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.40

1.24

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.64

1.21

1.6

1.3

41.80

47.63

umol/l

—

(3020650) Glucose [Presence] in Urine

2.31

1.18

1.3

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

102

1.67

1.16

1.5

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.06

1.15

1.1

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.50

1.15

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

431

1.31

1.14

1.2

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.69

1.13

1.8

2.0

18.40

147.84

ug/min

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.79

1.11

1.1

0.85

1.27

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1.73

1.09

1.1

0.15

0.52

u/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.92

1.02

6.2

7.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

273

1.36

1.01

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.89

1.01

1.1

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

115

1.57

0.99

16.1

9.9

—

(3011288) Drugs identified in Urine by Screen method

1.67

0.98

1.8

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.69

0.95

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.69

0.95

1.4

1.2

—

(44813793) Dust mix specific IgE antibody measurement

1.72

0.92

1.0

—

(3005570) Glucose [Moles/volume] in Urine

159

1.45

0.91

1.9

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

749

0.81

0.89

2.2

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

575

1.23

0.88

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

127

1.50

0.88

1.0

257.08

334.36

ng/l

1.11

(3032773) Endomysium IgG Ab [Titer] in Serum

1.58

0.87

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

129

1.48

0.83

1.0

764.36

626.53

ng/l

0.87

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

129

1.48

0.83

1.0

38.19

46.95

ng/l

0.69

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.88

0.82

1.0

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.73

0.79

1.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

462

4348

1.08

0.78

3.5

3.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

115

1.48

0.77

1.1

0.31

0.84

u/ml

—

(3016879) Cocaine [Presence] in Urine

124

1.46

0.75

1.7

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

100

1.50

0.73

2.7

1.7

138.47

90.31

umol/l

0.75

100

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.58

0.71

2.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

256

1.29

0.70

2.1

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.85

0.68

2.2

1.4

66.80

121.59

ng/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.67

0.68

7.7

7.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.60

0.68

1.0

1.1

4.50

2.52

u/ml

—

(3000764) Benzodiazepines [Presence] in Urine

127

1.42

0.68

1.7

1.4

—

(3027008) Opiates [Presence] in Urine

128

1.41

0.65

1.7

1.4

—

(3028300) Cannabinoids [Presence] in Urine

129

1.40

0.63

1.7

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

159

1440

1.11

0.63

1.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.50

0.63

2.3

2.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.64

0.62

1.3

1.4

8.06

9.42

ug/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.53

0.59

3.1

1.6

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.72

0.57

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.62

0.55

1.7

1.6

—

(3020491) Glucose [Moles/volume] in Blood

125

1.36

0.53

1.6

3.1

7.18

6.98

mmol/l

0.14

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.54

0.53

1.7

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.41

0.51

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

1.46

0.50

1.3

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

226

1.24

0.48

1.1

1.11

52.43

iu/ml

—

(3045716) Anion gap in Serum or Plasma

1.36

0.41

2.4

2.0

9.93

10.37

mmol/l

0.18

(21494755) Public health laboratory ask at order entry panel

604

0.87

0.41

1.2

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.41

0.0

1.1

—

9.77

—

(3014271) Vancomycin [Susceptibility]

105

1.34

0.41

4.1

3.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

335

1.17

0.38

2.0

1.5

—

(3027944) Amphetamines [Presence] in Urine

126

1.27

0.35

1.4

—

(4034850) Laboratory test

561

0.89

0.33

14.7

10.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

151

1423

1.07

0.30

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.31

0.30

1.5

2.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.29

0.30

1.2

9.48

9.74

mmol/l

0.08

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

198

2077

0.95

0.28

5.2

5.0

33.73

33.54

0.08

141

1358

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

21.71

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

154

1.17

0.21

1.7

1.2

1.61

1.46

nmol/l

0.33

133

(4146454) Self-monitoring of blood glucose

213

1.13

0.18

2.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.19

0.18

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

379

1.08

0.16

4.4

3.7

29.22

30.02

mg/l

0.06

244

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

225

0.89

0.16

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.14

0.15

1.3

1.4

134.98

163.48

pmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

132

1.14

0.13

1.9

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

478

0.94

0.12

1.8

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

424

0.94

0.11

1.7

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.04

0.08

1.6

1.4

1.56

1.54

g/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

216

2193

0.98

0.07

11.8

7.2

—

(3006462) Nitrate [Presence] in Urine

1.02

0.07

1.7

3.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

220

1.05

0.03

2.3

1.8

211.57

201.82

pmol/l

0.13

206

(3044242) Glucose [Moles/volume] in Arterial blood

105

0.95

0.00

2.1

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

161

0.99

0.00

1.9

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.96

0.00

1.0

—

2.48

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.5

—

2.17

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.2

—

7.47

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MGUS_WIDE – Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo (C3_MGUS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints